Partners Capital Investment Group LLP acquired a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 60,405 shares of the bi

L2 Asset Management LLC acquired a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 45,073 shares of the biopharmaceutical company

Quantbot Technologies LP purchased a new stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 33,000 shares of the biopharmaceutical comp

Van Hulzen Asset Management LLC acquired a new stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 16,914 shares of the biopharmaceutical co

Peak Asset Management LLC acquired a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 32,175 shares of the biopharmaceutical company

Cullen Capital Management LLC purchased a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,132,367 shares of the biopharmaceutical com

Te Ahumairangi Investment Management Ltd bought a new stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 79,705 shares of the biopharmaceutical company

Sanctuary Advisors LLC bought a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 384,190 shares of the biopharmaceu

Meiji Yasuda Asset Management Co Ltd. purchased a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 102,981 shares of the biopharmaceutic

Compass Financial Management LLC bought a new stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 14,966 shares of the biopharmaceutical company

Asset One Wealth Management LLC purchased a new stake in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 76,968 shares of the biopharmaceutical company

Osmosis Investment Management UK Ltd purchased a new stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 289,321 shares of the biopharmaceutical company

Cibc World Market Inc. bought a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 409,428 shares of the biopharmaceutical company

Barbara Oil Co. bought a new stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 42,000 shares of the biopharmaceutical company

Bristol Myers Squibb stock is anchored by a July 30, 2026 earnings beat, with $2.04 EPS on $12.97 bi

Haverford Trust Co purchased a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 40,920 shares of the biopharmaceutical company

GQG Partners LLC purchased a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 96,264 shares of the biopharmaceutical company

Varma Mutual Pension Insurance Co acquired a new position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 374,226 shares of the biopharmaceutical company

Daiichi Life Insurance Co. Ltd. bought a new stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund bought 99,653 shares of the biopharmaceutical company